Cefadroxil Hemihydrate Articles

GSK confirms emerging markets strategy, buying B-MS' Egyptian unit for $210M

27 October 2008

France to reimburse drugs at generics prices

30 June 2003

Indian bulk drug firms warned on overpricing

18 September 2000

180-day exclusivity: no new FDA regs soon, and pressure grows on FTC and

30 March 1999

India raises prices of three bulk drugs

26 February 1999

Strong Domestic Sales Growth For Bristol-Myers Squibb

23 July 1998

NEW YORK STOCK COMMENT

4 April 1994

STUDY SUPPORTS CEPHALOSPORIN USE

25 January 1993

NEW YORK STOCK COMMENT

7 September 1992

NEW YORK STOCK COMMENT

3 August 1992

ZENITH LABS' CEFADROXIL

4 May 1992

STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB

20 April 1992

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end